1 |
Zhou Y, Peng Y, Mao QQ, et al (2013). Casticin induces caspase-mediated apoptosis via activation of mitochondrial pathway and upregulation of DR5 in human lung cancer cells. Asian Pac J Trop Med, 6, 372-8.
DOI
ScienceOn
|
2 |
Zietman AL, Bae K, Slater JD, et al (2010). Randomized trial comparing conventional-dose with high-dose conformal radiation therapy in early-stage adenocarcinoma of the prostate: long-term results from proton radiation oncology group/american college of radiology 95-09. J Clin Oncol, 28, 1106-1.
DOI
ScienceOn
|
3 |
Gao HS, Rong X, Peng D, et al (2011). Cross-talk of the related bioactivity mediators in serum after injection of soluble TNF- receptor on silicosis model of rats. Toxicol Ind Health, 27, 607-16.
DOI
ScienceOn
|
4 |
Gautam SC, Xu YX, Dumaguin M, et al (2000). Resveratrol selectively inhibits leukemia cells: a prospective agent for ex vivo bone marrow purging. Bone Marrow Transplant, 25, 639-5.
DOI
ScienceOn
|
5 |
Habrand JL, De Crevoisier R (2001). Radiation therapy in the management of childhood brain tumors. Childs Nerv Syst, 17, 121-33.
DOI
ScienceOn
|
6 |
Hagan M, Wang L, Hanley JR, et al (2000). Ionizing radiation-induced mitogen-activated protein (MAP) kinase activation in DU145 prostate carcinoma cells: MAP kinase inhibition enhances radiation-induced cell killing and G2/M-phase arrest. Radiat Res, 153, 371-83.
DOI
ScienceOn
|
7 |
Hoppe-Hirsch E, Brunet L, Laroussinie F, et al (1995). Intellectual outcome in children with malignant tumors of the posterior fossa: influence of the field of irradiation and quality of surgery. Childs Nerv Syst, 11, 340-5.
DOI
|
8 |
Ivanov VN, Zhou H, Hei TK (2007). Sequential treatment by ionizing radiation and sodium arsenite dramatically accelerates TRAIL-mediated apoptosis of human melanoma cells. Cancer Res, 67, 5397-7.
DOI
ScienceOn
|
9 |
Johnson GE, Ivanov VN, Hei TK (2008). Radiosensitization of melanoma cells through combined inhibition of protein regulators of cell survival. Apoptosis, 13, 790-02.
DOI
ScienceOn
|
10 |
Kabakov AE, Kudryavtsev VA, Gabai VL (2010). Hsp90 inhibitors as promising agents for radiotherapy. J Mol Med, 88, 241-7.
DOI
ScienceOn
|
11 |
Leith JT (1994). In vitro radiation sensitivity of the LNCaP prostate tumor cell line. Prostate, 24, 119-4.
DOI
ScienceOn
|
12 |
Kao CL, Huang PI, Tsai PH, et al (2009). Resveratrol-induced apoptosis and increased radiosensitivity in CD 133-positive cells derived from atypical teratoid/rhabdoid tumor. Int J Radiat Oncol Biol Phys, 74, 219-8.
DOI
ScienceOn
|
13 |
Kelley MR (2012). DNA Repair in Cancer Therapy: Molecular Targets and Clinical Applications, Academic Press, New York, NY, USA.
|
14 |
Lee JC, Kinniry PA, Arguiri E, et al (2010). Dietary Curcumin increases antioxidant defenses in lung, ameliorates radiation-induced pulmonary fibrosis, and improves survival in mice. Radiat Res, 173, 590-01.
DOI
ScienceOn
|
15 |
Leone S, Fiore M, Lauro MG, et al (2008). Resveratrol and X rays affect gap junction intercellular communications in human glioblastoma cells. Mol Carcinog, 47, 587-98.
DOI
ScienceOn
|
16 |
Linard C, Marquette C, Mathieu J, et al (2004). Acute induction of inflammatory cytokine expression after gamma-irradiation in the rat: effect of an NF-kB inhibitor. Int J Radiat Oncol Biol Phys, 58, 427-4.
DOI
ScienceOn
|
17 |
Lu KH, Chen YW, Tsai PH, et al (2009). Evaluation of radiotherapy effect in resveratrol-treated medulloblastoma cancer stem-like cells. Childs Nerv Syst, 25, 543-0.
DOI
|
18 |
Machida H, Matsumoto Y, Shirai M, et al (2003). Geldanamycin, an inhibitor of Hsp90, sensitizes human tumour cells to radiation. Int J Radiat Biol, 79, 9730.
|
19 |
Mcllwain DR, Berger T, Mak TW (2013). Caspase functions in cell death and disease. Cold Spring Harb Perspect Med, 3, 8656.
|
20 |
Bao S, Wu Q, McLendon RE, et al (2006). Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature, 444, 756-0.
DOI
ScienceOn
|
21 |
Bastianetto S, Quirion R (2010). Heme oxygenase 1: another possible target to explain the neuroprotective action of resveratrol, a multifaceted nutrient-based molecule. Exp Neurol, 225, 237-9.
DOI
ScienceOn
|
22 |
Baur JA, Sinclair DA (2006). Therapeutic potential of resveratrol: the in vivo evidence. Nat Rev Drug Discov, 5, 493-06.
DOI
ScienceOn
|
23 |
Benitez DA, Hermoso MA, Pozo-Guisado E, et al (2009). Regulation of cell survival by resveratrol involves inhibition of NF kappa B-regulated gene expression in prostate cancer cells. Prostate, 69, 1045-4.
DOI
ScienceOn
|
24 |
Bisht KS, Bradbury CM, Mattson D, et al (2003). Geldanamycin and 17-allylamino-17-demethoxygeldanamycin potentiate the in vitro and in vivo radiation response of cervical tumor cells via the heat shock protein 90-mediated intracellular signaling and cytotoxicity. Cancer Res, 63, 8984-95.
|
25 |
Aravindan S, Natarajan M, Herman TS, et al (2013). Molecular basis of ‘hypoxic’ breast cancer cell radio-sensitization: phytochemicals converge on radiation induced Rel signaling. Radiat Oncol, 8, 46-7.
DOI
|
26 |
Baatout S, Derradji H, Jacquet P, et al (2005). Increased radiation sensitivity of an eosinophilic cell line following treatment with epigallocatechin-gallate,resveratrol and curcuma. Int J Mol Med, 15, 337-52.
|
27 |
Brown JM (1999). The hypoxic cell: A target for selective cancer therapy-Eighteenth Bruce F. Cain Memorial Award lecture. Cancer Res, 59, 5863-0.
|
28 |
Nguyen HG, Ravid K (2006). Tetraploidy/aneuploidy and stem cells in cancer promotion: the role of chromosome passenger proteins. J Cell Physiol, 208, 12-2.
DOI
ScienceOn
|
29 |
Moeller BJ, Dreher MR, Rabbani ZN, et al (2005). Pleiotropic effects of HIF-1 blockade on tumor radiosensitivity. Cancer Cells, 8, 99-10.
DOI
ScienceOn
|
30 |
Moon SH, Shin KH, Kim TH, et al (2009). Dosimetric comparison of four different external beam partial breast irradiation techniques: three-dimensional conformal radiotherapy, intensity-modulated radiotherapy, helical tomotherapy, and proton beam therapy. Radiother Oncol, 90, 66-3.
DOI
ScienceOn
|
31 |
Oh YC, Kang OH, Choi JG, et al (2009). Anti-inflammatory effect of resveratrol by inhibition of IL-8 production in LPS-induced THP-1 cells. Am J Chin Med, 37, 1203-14.
DOI
ScienceOn
|
32 |
Okada H, Mak TW (2004). Pathways of apoptotic and nonapoptotic death in tumour cells. Nat Rev Cancer, 4, 592-3.
DOI
ScienceOn
|
33 |
Pervaiz S (2003). Resveratrol: from grapevines to mammalian biology. FASEB J, 17, 1975-5.
DOI
ScienceOn
|
34 |
Pervaiz S (2004). Chemotherapeutic potential of the chemopreventive phytoalexin resveratrol. Drug Resist Updat, 7, 333-44.
DOI
ScienceOn
|
35 |
Presser LD, McRae S, Waris G (2013). Activation of TGF-b1 promoter by hepatitis C virus-induced AP-1 and Sp1: role of TGF-b1 in hepatic stellate cell activation and invasion. PLoS ONE, 8, 56367.
DOI
|
36 |
Rashid A, Liu C, Sanli T, et al (2011). Resveratrol enhances prostate cancer cell response to ionizing radiation. Modulation of the AMPK, Akt and mTOR pathways. Radiat Oncol, 6, 144-55.
DOI
|
37 |
Chiou SH, Kao CL, Chen YW, et al (2008a). Identification of CD133-positive radioresistant cells in atypical teratoid/rhabdoid tumor. PLoS ONE, 3, 2090.
DOI
ScienceOn
|
38 |
Busquets S, Ametller E, Fuster G, et al (2007). Resveratrol, a natural diphenol, reduces metastatic growth in an experimental cancer model. Cancer Lett, 245, 144-8.
DOI
ScienceOn
|
39 |
Camphausen K, Tofilon PJ (2004). Combining radiation and molecular targeting in cancer therapy. Cancer Biol Ther, 3, 247-0.
DOI
|
40 |
Carsten RE, Bachand AM, Bailey SM, et al (2008). Resveratrol reduces radiation-induced chromosome aberration frequencies in mouse bone marrow cells. Radiat Res, 169, 633-8.
DOI
ScienceOn
|
41 |
Collins R, Darby S, Davies C, et al (2005). Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of randomized trials. Lancet, 366, 2087-106.
DOI
ScienceOn
|
42 |
Creagh, EM, Martin SJ (2001). Caspases: cellular demolition experts. Biochem Soc Trans, 29, 696-2.
DOI
ScienceOn
|
43 |
Crook JM, Perry GA, Robertson S, et al (1995). Routine prostate biopsies following radiotherapy for prostate cancer: results for 226 patients. Urology, 45, 624-1.
DOI
ScienceOn
|
44 |
de la Lastra CA, Villegas I (2007). Resveratrol as an antioxidant and pro-oxidant agent: mechanisms and clinical implications. Biochem Soc Trans, 35, 1156-0.
DOI
ScienceOn
|
45 |
Debatin KM, Krammer PH (2004). Death receptors in chemotherapy and cancer. Oncogene, 23, 2950-66.
DOI
ScienceOn
|
46 |
Sowa M, Arthurs BJ, Estes BJ, et al (2006). Effects of ionizing radiation on cellular structures, induced instability and carcinogenesis. EXS, 96, 293-1.
|
47 |
Reagan-Shaw S, Mukhtar H, Ahmad N (2008) Resveratrol imparts photoprotection of normal cells and enhances the efficacy of radiation therapy in cancer cells. Photochem Photobiol, 84, 415-1.
DOI
ScienceOn
|
48 |
Ruan K, Song G, Ouyang G (2009). Role of hypoxia in the hallmarks of human cancer. J Cell Biochem, 107, 1053-2.
DOI
ScienceOn
|
49 |
Scarlatti F, Sala G, Ricci C, et al (2007). Resveratrol sensitization of DU145 prostate cancer cells to ionizing radiation is associated to ceramide increase. Cancer Lett, 253, 124-0.
DOI
ScienceOn
|
50 |
Suit H, Goldberg S, Niemierko A, et al (2007). Secondary carcinogenesis in patients treated with radiation: a review of data on radiation-induced cancers in human, non-human primate, canine and rodent subjects. Radiat Res, 167, 12-42.
DOI
ScienceOn
|
51 |
Tak JK, Lee JH, Park JW (2012). Resveratrol and piperine enhance radiosensitivity of tumor cells. BMB Rep, 45, 242-6.
DOI
ScienceOn
|
52 |
Ungvari Z, Labinskyy N, Mukhopadhyay P, et al (2009). Resveratrol attenuates mitochondrial oxidative stress in coronary arterial endothelial cells. Am J Physiol Heart Circ Physiol, 297, 1876-1.
DOI
ScienceOn
|
53 |
Wang C, Chen L, Hou X, et al (2006). Interactions between E2F1 and SirT1 regulate apoptotic response to DNA damage. Nat Cell Biol, 8, 1025-1.
DOI
ScienceOn
|
54 |
Wang H, Lathia JD,Wu Q, et al (2009). Targeting interleukin 6 signaling suppresses glioma stem cell survival and tumor growth. Stem Cells, 27, 2393-04.
DOI
ScienceOn
|
55 |
Elmore E, Lao XY, Kapadia R, et al (2006). The effect of dose rate on radiation-induced neoplastic transformation in vitro by low doses of low-LET radiation. Radiat Res, 166, 832-8.
DOI
ScienceOn
|
56 |
Delmas D, Jannin B, Latruffe N (2005). Resveratrol: preventing properties against vascular alterations and ageing. Mol Nutr Food Res, 49, 377-95.
DOI
ScienceOn
|
57 |
Dennis M, Spiegler BJ, Hetherington CR, et al (1996). Neuropsychological sequelae of the treatment of children with medulloblastoma. J Neurooncol, 29, 91-1.
DOI
|
58 |
Di Franco R, Calvanese M, Murino P, et al (2012). Skin toxicity from external beam radiation therapy in breast cancer patients: protective effects of Resveratrol, Lycopene, Vitamin C and anthocianin (). Radiat Oncol, 7, 12-8.
DOI
|
59 |
Fang Y, Bradley MJ, Cook KM, Herrick EJ, Nicholl MB (2013). A potential role for resveratrol as a radiation sensitizer for melanoma treatment. J Surg Res, 183, 645-3.
DOI
ScienceOn
|
60 |
Fang Y, DeMarco VG, Nicholl MB (2012). Resveratrol enhances radiation sensitivity in prostate cancer by inhibiting cell proliferation and promoting cell senescence and apoptosis. Cancer Sci, 103, 1090-8.
DOI
ScienceOn
|
61 |
Filomeni G, Graziani I, Rotilio G, et al (2007). Trans-Resveratrol induces apoptosis in human breast cancer cells MCF-7 by the activation of MAP kinases pathways. Genes Nutr, 2, 295-5.
DOI
ScienceOn
|
62 |
Forman JD, Oppenheim T, Liu H, et al (1993). Frequency of residual neoplasm in the prostate following three-dimensional conformal radiotherapy. Prostate, 23, 235-3.
DOI
ScienceOn
|
63 |
Fremont L (2000). Biological effects of resveratrol. Life Sci, 66, 663-3.
DOI
ScienceOn
|
64 |
Yin HT, Tian QZ, Guan L, et al (2013). In vitro and in vivo evaluation of the antitumor efficiency of resveratrol against lung cancer. Asian Pac J Cancer Prev, 14, 1703-6.
DOI
ScienceOn
|
65 |
Weiss JF, Landauer MR (2003). Protection against ionizing radiation by antioxidant nutrients and phytochemicals. Toxicology, 189, 1-20.
DOI
ScienceOn
|
66 |
Xie Y, Zhang J, Xu Y, et al (2012). SirT1 confers hypoxia-induced radioresistance via the modulation of c-Myc stabilization on hepatoma cells. J Radiat Res, 53, 44-0.
DOI
|
67 |
Yang YP, Chang YL, Huang PI, et al (2012). Resveratrol suppresses tumorigenicity and enhances radiosensitivity in primary glioblastoma tumor initiating cells by inhibiting the STAT3 axis. J Cell Physiol, 227, 976-93.
DOI
ScienceOn
|